Showing results (11-20 of 46) with videos related to
Sort By:
Pageof 5
Quantitative Imaging in Medicine and Surgery|August 11, 2025
Comparison of standardized uptake value and standardized uptake lean body mass metrics in 18F-fluorodeoxyglucose positron emission tomography for assessing transformation in chronic lymphocytic leukemia and follicular lymphomaJorge D Oldan, Christopher E Jensen, Deborah M Stephens, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2022
Treatment Outcomes and Roles of Transplantation and Maintenance Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma: Results From Large Real-World CohortsPeter Martin, Jonathon B Cohen, Michael Wang, et al.British Journal of Haematology|July 23, 2016
A phase II trial of bendamustine in combination with rituximab in older patients with previously untreated diffuse large B-cell lymphomaSteven I Park, Natalie S Grover, Oludamilola Olajide, et al.Experimental Hematology & Oncology|May 14, 2025
Impact of diagnosis to treatment interval on outcomes in patients with newly diagnosed marginal zone lymphoma - a US multisite studyNarendranath Epperla, Geoffrey Shouse, Natalie S Grover, et al.Journal for Immunotherapy of Cancer|August 1, 2023
Patient-reported outcomes in CD30-directed CAR-T cells against relapsed/refractory CD30+ lymphomasNicholas P Tschernia, Hillary Heiling, Allison M Deal, et al.PLOS Digital Health|February 22, 2023
Wearable sensor-based performance status assessment in cancer: A pilot multicenter study from the Alliance for Clinical Trials in Oncology (A19_Pilot2)William A Wood, Deepika Dilip, Andriy Derkach, et al.Hematological Oncology|April 22, 2025
Impact of Age on Biology, Presentation and Outcomes in Marginal Zone Lymphoma: Results From a Multicenter Cohort StudyPallawi Torka, Natalie S Grover, Timothy J Voorhees, et al.Blood Cancer Journal|October 18, 2024
Evaluation of Ki-67 expression and large cell content as prognostic markers in MZL: a multicenter cohort studyNatalie S Grover, Kaitlin Annunzio, Marcus Watkins, et al.Leukemia & Lymphoma|June 12, 2019
Clinicopathologic correlates of MYD88 L265P mutation and programmed cell death (PD-1) pathway in primary central nervous system lymphomaTarsheen K Sethi, Alexandra E Kovach, Natalie S Grover, et al.Blood Advances|July 10, 2024
CD19-directed CART therapy for T-cell/histiocyte-rich large B-cell lymphomaPriyanka A Pophali, Joshua A Fein, Kwang W Ahn, et al.Pageof 5